WWA
DGX icon

Wealth Watch Advisors’s Quest Diagnostics DGX Stock Holding History

Wealth Watch Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4
Closed -$694 – 313
2025
Q4 		$694 Sell
4
-3
-43% -$546 ﹤0.01% 832
2025
Q3 		$1.33K Buy
+7
New +$1.24K ﹤0.01% 717

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Wealth Watch Advisors's DGX Position: Q1 2026 in Review

Wealth Watch Advisors sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 4 shares — an estimated $694 sold.

Wealth Watch Advisors first reported a position in DGX in Q3 2025 and held it in 2 quarters. The position peaked at $1.33K in Q3 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Wealth Watch Advisors reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Wealth Watch Advisors sold 4 Quest Diagnostics shares in Q1 2026, an estimated $694.
  • Wealth Watch Advisors first reported a position in Quest Diagnostics in Q3 2025 and held it in 2 quarters.
  • Wealth Watch Advisors's Quest Diagnostics position peaked at $1.33K in Q3 2025.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Wealth Watch Advisors's 13F filing for Q1 2026, filed 15 May 2026.